Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Public ClinicalTrials.gov record NCT00423657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin and Skin Structure Infection (cSSSI)
Study identification
- NCT ID
- NCT00423657
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 680 participants
Conditions and interventions
Conditions
Interventions
- ceftaroline Drug
- vancomycin plus aztreonam Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2007
- Primary completion
- Nov 30, 2007
- Completion
- Nov 30, 2007
- Last update posted
- Mar 13, 2017
2007
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Buena Park | California | 90620 | — |
| Investigational Site | Hawaiian Gardens | California | 90716 | — |
| Investigational Site | Los Angeles | California | 90033 | — |
| Investigational Site | Pasadena | California | 91105 | — |
| Investigational Site | San Diego | California | 92114 | — |
| Investigational Site | San Jose | California | 95124 | — |
| Investigational Site | Atlantis | Florida | 33462 | — |
| Investigational Site | Columbus | Georgia | 31904 | — |
| Investigational Site | Marietta | Georgia | 30060 | — |
| Investigational Site | Springfield | Illinois | 62701 | — |
| Investigational Site | Baltimore | Maryland | 21201 | — |
| Investigational Site | Minneapolis | Minnesota | 55422 | — |
| Investigational Site | Butte | Montana | 59701 | — |
| Investigational Site | Somers Point | New Jersey | 08244 | — |
| Investigational Site | Toledo | Ohio | 43608 | — |
| Investigational Site | Tacoma | Washington | 98405 | — |
| Investigational Site | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00423657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00423657 live on ClinicalTrials.gov.